Aerobic Exercise for Type 1 Diabetes
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to understand how aerobic exercise affects blood sugar levels in women with type 1 diabetes who use birth control pills. Participants will wear a device to track glucose levels during different phases of their menstrual cycle and perform a 45-minute cycling workout. The trial is suitable for women diagnosed with type 1 diabetes for at least a year, who have regular periods, use birth control pills, and live in Edmonton, Alberta. As an unphased trial, it offers participants the chance to contribute to valuable research that could enhance diabetes management for women.
Will I have to stop taking my current medications?
The trial requires that you do not use medications (other than insulin) that would affect blood glucose levels. If you are taking such medications, you may need to stop them to participate.
What prior data suggests that aerobic exercise is safe for females with type 1 diabetes?
Research has shown that regular aerobic exercise is generally safe and offers many health benefits for people with type 1 diabetes. Studies indicate that moderate exercise, such as 45-minute sessions at 60% of maximum aerobic capacity, can lower blood sugar levels from about 155 mg/dL to 110 mg/dL. This decrease occurs whether the exercise is done during the follicular phase or the luteal phase of the menstrual cycle.
Exercise affects blood sugar levels differently depending on the menstrual phase. During the luteal phase, higher blood sugar levels might help prevent low blood sugar (hypoglycemia) after exercise. However, during the follicular phase, there is a higher chance of experiencing high blood sugar (hyperglycemia) 24 hours after exercising.
Overall, these findings suggest that the exercise in this study is well-tolerated and has predictable effects on blood sugar, making it safe for participants with type 1 diabetes.12345Why are researchers excited about this trial?
Researchers are excited about aerobic exercise as a treatment for Type 1 Diabetes because it offers a natural and holistic approach that differs from the traditional reliance on insulin and glucose-monitoring technologies. Unlike conventional treatments that focus primarily on blood sugar regulation through medication, aerobic exercise can enhance overall metabolic health and improve insulin sensitivity without additional drugs. By examining the effects of exercise during different phases of the menstrual cycle (follicular and luteal), this approach could provide personalized insights into how exercise timing might optimize glucose control for women with Type 1 Diabetes, potentially leading to more tailored and effective management strategies.
What evidence suggests that aerobic exercise could be effective for type 1 diabetes?
Research has shown that aerobic exercise can help control blood sugar levels in people with type 1 diabetes. One study found that blood sugar levels dropped from about 155 mg/dL to 110 mg/dL after moderate aerobic exercise, regardless of the menstrual phase. This indicates that exercise can effectively manage blood sugar. During the luteal phase (the second half of the menstrual cycle), slight differences in blood sugar response to exercise occurred, but exercise remained beneficial overall. In summary, aerobic exercise is a promising way to manage diabetes, even with the natural changes of the menstrual cycle.12346
Are You a Good Fit for This Trial?
This trial is for women with type 1 diabetes who've had it for at least a year, live in Edmonton, have regular menstrual cycles, and use monophasic oral contraceptives. It's not for those with heart disease, severe nerve damage, recent insulin changes, high blood pressure, certain eye conditions, or on medications affecting blood sugar.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Pre-test Measures
Participants undergo pre-test measures including questions about menstrual cycle, physical activity, medication, blood pressure, anthropometric measurements, blood sample for HbA1c, and an incremental treadmill test to determine aerobic capacity.
Testing Sessions
Participants perform two testing sessions with aerobic exercise and continuous glucose monitoring, separated by at least 5 days. Sessions occur during different phases of the menstrual cycle.
Follow-up
Participants are monitored for changes in blood glucose and other secondary outcomes post-exercise.
What Are the Treatments Tested in This Trial?
Interventions
- Follicular Phase Aerobic Exercise
- Luteal Phase Aerobic Exercise
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alberta
Lead Sponsor
Women and Children's Health Research Institute, Canada
Collaborator